PBH
Prestige Consumer Healthcare Inc
Price:  
67.93 
USD
Volume:  
396,274.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PBH Relative Valuation

76.9%
Upside

As of 2026-03-06, the Relative Valuation of Prestige Consumer Healthcare Inc (PBH) is 120.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 67.93 USD, the upside of Prestige Consumer Healthcare Inc based on Relative Valuation is 76.9%.

The range of the Relative Valuation is 78.67 - 161.88 USD.

Range Selected
Trailing P/E multiples 20.0x - 30.7x 25.9x
Forward P/E multiples 26.0x - 35.8x 30.6x
Fair Price 78.67 - 161.88 120.15
Upside 15.8% - 138.3% 76.9%
67.93 USD
Stock Price
120.15 USD
Fair Price

PBH Relative Valuation - Historical P/E Data

Date P/E
2026-03-04 17.56
2026-03-03 17.51
2026-03-02 17.39
2026-02-27 17.58
2026-02-26 17.81
2026-02-25 17.60
2026-02-24 17.45
2026-02-23 17.68
2026-02-20 17.65
2026-02-19 17.51
2026-02-18 16.88
2026-02-17 16.81
2026-02-13 16.95
2026-02-12 16.99
2026-02-11 16.74
2026-02-10 16.77
2026-02-09 16.58
2026-02-06 16.83
2026-02-05 16.63
2026-02-04 17.01
2026-02-03 16.35
2026-02-02 16.60
2026-01-30 16.36
2026-01-29 16.21
2026-01-28 16.02
2026-01-27 16.21
2026-01-26 16.66
2026-01-23 16.70
2026-01-22 17.18
2026-01-21 17.00
2026-01-20 16.43
2026-01-16 16.52
2026-01-15 16.65
2026-01-14 16.44
2026-01-13 16.42
2026-01-12 16.57
2026-01-09 16.28
2026-01-08 16.23
2026-01-07 15.92
2026-01-06 15.92
2026-01-05 15.85
2026-01-02 15.53
2025-12-31 15.65
2025-12-30 15.79
2025-12-29 16.16
2025-12-26 15.94
2025-12-24 15.84
2025-12-23 15.81
2025-12-22 15.90
2025-12-19 15.66